Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

TPEX:4186 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	106.32	182.14	158.56	159.7	236.89
Cash & Short-Term Investments	106.32	182.14	158.56	159.7	236.89
Cash Growth	-41.62%	14.87%	-0.71%	-32.59%	122.95%
Accounts Receivable	97.56	51.84	62.43	67.29	52.83
Other Receivables	-	-	0.25	0.13	0.96
Receivables	97.56	51.84	62.68	67.43	53.79
Inventory	19.16	21.17	23.42	24.11	25.01
Prepaid Expenses	-	3	-	-	31.11
Other Current Assets	5.4	1.16	15.48	16.42	0.55
Total Current Assets	228.45	259.3	260.13	267.66	347.35
Property, Plant & Equipment	234.03	246.27	255.02	256.79	261.3
Long-Term Investments	78.23	93.9	72.94	67.75	52.49
Other Intangible Assets	0.2	0.22	3.53	10.14	24.07
Long-Term Deferred Tax Assets	9.88	9.81	8.82	8.73	13.07
Other Long-Term Assets	125.65	139.08	106.34	102.67	125.17
Total Assets	676.42	748.57	706.77	713.74	823.45
Accounts Payable	8.48	16.65	14.55	11.55	14.44
Accrued Expenses	31.94	-	-	-	-
Short-Term Debt	140	180	130.95	107.86	116.91
Current Portion of Long-Term Debt	24.54	36.52	35.71	20.92	13.75
Current Portion of Leases	4.38	3.83	4.65	4.4	8.78
Current Unearned Revenue	26.86	26.77	26.06	60.98	15.7
Other Current Liabilities	2.69	53.05	31.15	39.36	46.37
Total Current Liabilities	238.88	316.82	243.07	245.08	215.95
Long-Term Debt	58.65	83.18	103.27	108.08	115.29
Long-Term Leases	2.08	3.71	5.12	7.7	11.81
Long-Term Unearned Revenue	118.54	109.08	109.07	109.63	117.22
Long-Term Deferred Tax Liabilities	0.85	0.97	0.71	-	-
Other Long-Term Liabilities	0.98	0.89	0.89	1.01	1.87
Total Liabilities	419.98	514.65	462.13	472.29	464.55
Common Stock	900	900	900	900	900
Additional Paid-In Capital	-	-	-	0.05	150
Retained Earnings	-642.51	-665.72	-654.95	-658.6	-691.1
Comprehensive Income & Other	-1.05	-0.36	-0.4	-	-
Shareholders' Equity	256.44	233.92	244.64	241.45	358.9
Total Liabilities & Equity	676.42	748.57	706.77	713.74	823.45
Total Debt	229.64	307.24	279.7	248.97	266.53
Net Cash (Debt)	-123.32	-125.11	-121.15	-89.27	-29.64
Net Cash Per Share	-1.37	-1.39	-1.35	-0.99	-0.37
Filing Date Shares Outstanding	90	90	90	90	90
Total Common Shares Outstanding	90	90	90	90	90
Working Capital	-10.44	-57.52	17.07	22.58	131.4
Book Value Per Share	2.85	2.60	2.72	2.68	3.99
Tangible Book Value	256.25	233.7	241.11	231.31	334.83
Tangible Book Value Per Share	2.85	2.60	2.68	2.57	3.72
Land	127.13	127.13	127.13	118.51	118.51
Buildings	81.12	81.12	81.12	77.61	77.61
Machinery	228.15	226.64	219.34	217.25	196.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.